Ozempic Users Face Double Risk of Rare Vision Loss, Nordic Studies Find
Ozempic Users Face Double Risk of Rare Vision Loss, Nordic Studies Find
Danish researchers are raising concerns about the widely prescribed diabetes drug Ozempic after discovering that it significantly increases patients’ risk of experiencing what doctors describe as a “stroke of the optic nerve.”
The study findings, published in the International Journal of Retina and Vitreous, suggest that the use of Ozempic (semaglutide) more than doubles the risk of developing non-arteritic anterior ischemic optic neuropathy (NAION), a serious eye condition characterized by sudden vision loss in one eye, because of inadequate blood flow to the optic nerve. NAION is considered the most common cause of sudden vision loss in people older than 50.
more >>>
